{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack", "item": "https://www.patentleaderboard.com/patent/11286307"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

US Patent 11286307 · Granted Mar 29, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Assays for determining plasma kallikrein system biomarkers2025
Monoclonal antibody inhibitor of Factor XIIa2025
Plasma kallikrein binding proteins and uses thereof in treating hereditary angio2025
Plasma kallikrein binding proteins and uses thereof in treating hereditary angio2025
Bispecific antibodies against plasma kallikrein and factor XII2025
Diagnosis and treatment of autoimmune diseases2024
Bispecific antibodies against plasma kallikrein and Factor XII2022
Assays for determining plasma kallikrein system biomarkers2022
Compositions and methods for making and using anti-myostatin antibodies2021
Methods of determining levels of cleaved and/or intact kininogen2021
Methods of determining levels of cleaved and/or intact kininogen2021
Plasma kallikrein binding proteins and uses thereof in treating hereditary angio2021